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Edited by Maurice MontalAbstract Inward rectiﬁer potassium Kir2.x channels mediate
cardiac inward rectiﬁer potassium currents (IK1). As a subunit
of Kir2.x, the physiological role of Kir2.3 in native cardiomyo-
cytes has not been reported. This study shows that Kir2.3
knock-down remarkably down-regulates Kir2.3 expression
(Kir2.3 protein was reduced to 19.91 ± 3.24% on the 2nd or 3rd
day) and IK1 current densities (at 120 mV, control vs. knock-
down: 5.03 ± 0.24 pA/pF, n = 5 vs. 1.16 ± 0.19 pA/pF, n =
7, P < 0.001) in neonatal rat cardiomyocytes. The data suggest
that Kir2.3 plays a potentially important role in IK1 currents in
neonatal rat cardiomyocytes.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Inward rectiﬁer potassium current (IK1) is a key element in
determining resting membrane potential and late phase repo-
larization of ventricular action potential [1]. Abnormality of
IK1 can lead to Andersons syndrome [2], short QT syndrome
[3], ventricular ﬁbrillation [4,5] and alterations of cardiac excit-
ability [6–8].
IK1 is mediated by the inward rectiﬁer potassium Kir2.x
channels. Kir2.x channels consist of four members (Kir2.1–
Kir2.4). With the exception of Kir2.4 [9], Kir2.1, Kir2.2 and
Kir2.3 express in human [10], rat [11] and mouse cardiomyo-
cytes [12]. Kir2.x channel subunits can form homotetramers
[13] or heterotetramers [14]. Limited research has been
conducted on the speciﬁc functions of various Kir2.x channel
subunits in native cardiomyocytes. Kir2.1/ mouse cardio-
myocytes lack detectable IK1, and display broader action po-
tential; about 50% reduction in IK1 was observed in Kir2.2
/
 mouse cardiomyocytes [15]. However, up to date the physi-
ological role of Kir2.3 in native cardiomyocytes has not been*Corresponding author. Address: Department of Cardiology, Tongji
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doi:10.1016/j.febslet.2008.05.023reported. To investigate the contribution of Kir2.3 to IK1 cur-
rents in native cardiomyocytes, we used the RNA interference
to down-regulate the Kir2.3 channels subunit in neonatal rat
cardiomyocytes and recorded the IK1 current by whole-cell
patch-clamping.2. Materials and methods
2.1. Preparation of primary neonatal rat cardiomyocytes
All animal experiments were approved by the Animal Experiments
Committee of Tongji University and conform to the Guide for the
Care and Use of Laboratory Animals (1996) according to the US Na-
tional Institutes of Health. Cultures of neonatal rat cardiomyocytes
(NRCM) were prepared as described [16]. In brief, ventricles of 1-
day-old Sprague–Dawley rats were dissociated enzymatically at room
temperature using protease RDB (Sigma Chemical Co., St. Louis,
MO, USA). The enzyme was diluted 1:100 in phosphate-buﬀered sal-
ine (PBS) containing glucose (1 mg/ml) and antibiotics (100 U/ml pen-
icillin, 100 mg/ml streptomycin). At the end of a 10-min cycle of
digestion, the cardiomyocytes were collected by 10-min centrifugation
at 1600 rpm. To remove the RDB, each cell pellet was rinsed with
Hams F10 (Gibco, Grand Island, NY, USA) and resuspended in
growth medium (Hams F10 supplemented with 5% fetal serum, 5%
horse serum, 100 U/ml penicillin, 100 mg/ml streptomycin), 1 mM
CaCl2, and 50 mg/100 ml bromodeoxyuridine (BrdU) (Fluka, Buchs,
Switzerland), which also reduced the number of non-myocytic cells.
The cultures were maintained in a humidiﬁed incubator (Thermo For-
ma, Marietta, OH, USA) with an atmosphere of 5% CO2 and 95% air
at 37 C. Unsettled cells were washed after 24 h, and growing medium
was replaced daily.
2.2. Stealth RNAi
Stealth RNAi duplexes (Invitrogen Corporation, Carlsbad, CA,
USA) were designed to KCNJ4 (Genbank accession number:
NM_053870) using the BLOCK-iT RNAi Designer at http://
www.invitrogen.com/rnaidesigner (also see the reference [17]). For se-
quence information on the Stealth RNAi duplexes, see Table 1.
2.3. Transfection
NRCMwere plated with 100 nM Stealth RNAi or 100 nM BLOCK-
iT Fluorescent Oligo complexed with 2 lg/ml Lipofectamine 2000
(Invitrogen Corporation, Carlsbad, CA, USA) according to the man-
ufacturers instructions (10000 cells per well) for 24 h prior to transfec-
tion. BLOCK-iT Fluorescent Oligo is a highly stable, ﬂuorescein-
labeled and non-targeted dsRNA compound. It allows for visual mon-
itoring of transfection eﬃciency. After 24 h, transfection eﬃciency was
assessed by visualizing uptake of the BLOCK-iT Fluorescent Oligo
using ﬂuorescence microscopy. Transfection media were replaced at
24 h with fresh growth media and incubation continued for additional
24 h. At 24 and 48 h after transfection, total RNA was harvested fromblished by Elsevier B.V. All rights reserved.
Table 1
Sequence information for Stealth RNAi duplexes
KCNJ4 (GenBank
accession number
NM_053870)
Stealth sequence (50–3 0)
RSS331982 Sense AAUGUCAUAGCCCACGUUGAGGUCC
Antisense GGACCUCAACGUGGGCUAUGACAUU
RSS331980 Sense AAAUGUUGUCCAGAGGAAGGGUAGC
Antisense GCUACCCUUCCUCUGGACAACAUUU
RSS331981 Sense AACCCAUAACCGUAGGUCGUCUGUG
Antisense CACAGACGACCUACGGUUAUGGGUU
Negative control sense UUCUCCGAACGUGUCACGUTT
Antisense ACGUGACACGUUCGGAGAATT
Y. He et al. / FEBS Letters 582 (2008) 2338–2342 2339individual cell wells. The amount of RNA was quantiﬁed using a spec-
trophotometer. At 48 h, transfected cells in corresponding wells were
harvested for Western blot analysis, and cellular phenotype was veri-
ﬁed by immunoﬂuorescent laser scanning confocal microscopy [17].
2.4. Reverse transcription polymerase chain reaction (RT-PCR)
analysis
Total RNA was extracted from the control cells at days 1–3 and the
siRNA-treated-cells at 24 and 48 h using trizol (Invitrogen Corpora-
tion, Carlsbad, CA, USA) as previously described [18]. cDNA was syn-
thesized in 50 ll volumes using 1 lg of RNA, 0.5 ll of oligo dT-
Adaptor primer, 10 nmol of dNTPs, and 2.5 U of AMV-reverse trans-
criptase (Takara, Kyoto, Japan). Reverse transcription was conducted
under the conditions of 30 C for 10 min, 50 C for 30 min, 99 C for
5 min, and 5 C for 5 min. To amplify mRNAs, 10 ll of cDNAwas sub-
jected to PCR using 1.25 U of Ex Taq HS (Takara, Kyoto, Japan). The
ampliﬁcation scheme consisted of 2 min incubation at 94 C, followed
by 30 s at 94 C (melting), 30 s at 54.8 C to 60 C (annealing), and
55 s to 90 s at 74 C (extension), over 36–38 cycles. The following prim-
ers were used: atgccttccaggatgacaac (Kir2.1 sense), ccccttggaccagatag-
aca (Kir2.1 antisense) to generate a 174 bp PCR product;
tgtatacacacgggcaagga (Kir2.2 sense), acaaactgcctgatccatcc (Kir2.2 anti-
sense) to generate a 376 bp PCR product; caggcccacgtgcccaggcgga
(Kir2.3 sense), tacatgcatgatacacggtttg (Kir2.3 antisense) to generate a
330 bp PCR product; tgtgatgg- tgggtatgggtcagaag (b-actin sense),
tcacggttggccttagggttcagag (b-actin antisense). For the purpose of stan-
dardization, RT-PCR of b-actin was performed in parallel. Densitom-
etry was used for quantiﬁcation of PCR products, which were
visualized under UV light with ethidium bromide staining in 1.5% aga-
rose gel. Ethidium bromide ﬂuorescence images were captured by a
Nighthawk camera (Nighthawk; JAI Inc., Glostrup, Denmark) under
UV light. A DNA mass marker (100 ng) was used to analyze the size
and quantity of PCR products. The density of the corresponding bands
was measured quantitatively using image analysis software Bandscan
5.0 (Glyko, Novato, CA, USA) and corrected by reference to the value
for b-actin.
2.5. Western blotting
NRCM were collected from corresponding plates. To limit the ef-
fects of the proteases, the lysis buﬀer containing the following protease
inhibitors (Sigma Chemical Co.): 10 mg/ml leupeptin, 10 mg/ml apro-
tinin, and 1 mM phenylmethylsulfonyl ﬂuoride were applied. The pro-
tein samples were loaded on 10% polyacrylamide gels and
electrophoretically separated. Subsequently, the proteins were trans-
ferred to polyvinilidine diﬂuoride membranes (Millipore UK, Watford,
UK). After transferring, the membranes were blocked with 0.1%
Tween 20 (TBST) in 5% non-fat dry milk (NFDM) based on Tris-buf-
fered saline (TBS). The primary antibodies [anti-Kir2.1 (1:200), anti-
Kir2.2 (1:200) anti-Kir2.3 (1:200), Alomone Labs, Jerusalem, Israel]
were diluted with 1% NFDM in TBST and incubated with the mem-
brane overnight at 4 C. After the primary antibodies were washed
three times in TBST and a further blocking of the membranes with
1% NFDM in TBST, the secondary antibody [anti-rabbit IgG-horse
radish peroxidase (1:2000), Santa Cruz Biotechnology, Santa Cruz,
CA, USA] was diluted in 5% NFDM and applied to the membranes
for 1 h at room temperature. Finally, after the secondary antibody
was washed three times in TBST, the membranes were incubated with
HRP labeled goat-anti-rabbit antibody (Santa Cruz Biotechnology),and the results were recorded on Biomax ML ﬁlm (Eastman Kodak,
Rochester, NY, USA) [19].2.6. Immunoﬂuorescence staining and confocal scanning
NRCM, cultured on PDL/laminin-coated glass cover-slips in a cul-
ture chamber, were subjected to immunostaining for 48 h. The cells
were ﬁxated at 4 C in PBS-1% formalin (15 min) (Merck KGaA,
Darmstadt, Germany). Next, the cells were labeled with one of the fol-
lowing antibodies, rabbit anti-Kir2.1, rabbit anti-Kir2.2, rabbit anti-
Kir2.3 (Alomone Labs) at a dilution of 1:200 in PBS-1% FBS at
4 C for 24 h. Excess primary antibody was removed through a triple
wash in PBS-1% FBS, and the cells were stained with FITC-conjugated
anti-rabbit IgG (Jackson ImmunoResearch, West Grove, PA, USA),
at dilutions of 1:100 in PBS-1% FBS at 4 C for 1 h. After the IgG
was washed three times with PBS-1% FBS, the coverslips were
mounted onto glass slides. Examination of the slides was performed
using FCS-SP2 laser confocal microscope (Leica TCS SP, Leica La-
ser-technik, Heidelberg, Germany). Images of tissue sections and iso-
lated cells were obtained with an inverted confocal microscope
combined with Leica confocal software (excitation: 510 nm, emission:
488 nm). The ﬂuorescent density was analyzed by Image J 1.37v (NIH,
USA).2.7. Electrophysiology
Whole-cell patch-clamp recordings were made at room temperature
(24 C) using an EPC-10 ampliﬁer and pulse software (HEKA, Lambr-
echt, Germany) on the 2nd or 3rd day. The patch pipettes were pulled by
P97 puller (Sutter,Novato, CA,USA) and ﬁre-polished. The series resis-
tance was compensated (70%) and cell capacitance was determined by
analog measurement with the patch-clamp ampliﬁer. Currents were ﬁl-
tered with a cut-oﬀ frequency of 5 kHz and sampled at 10 kHz. During
recordings of inwardly rectifying potassium currents, the extracellular
solution was composed of (mM): 136 NaCl, 10 glucose, 10 HEPES, 4
KCl, 2MgCl2 and 1.0 CaCl2 (pH 7.4 withNaOH). Electrodes were ﬁlled
with (mM): 135 KCl, 10 EGTA, 10 HEPES, 5 Mg-ATP and 5 glucose
(pH 7.3 with KOH). TTX (1 lM, Calbiochem, La Jolla, CA, USA)
was used to block voltage-dependent sodium channels. Nifedipine
(1 lM, SigmaChemical Co.) was used to block L-type calcium channels.
The application of 2 mMBaCl2 (Sigma Chemical Co.) was used to iden-
tify IK1 currents from the NRCM.
2.8. Statistics
Voltage-clamp data were compiled and analysed using Pulseﬁt
(HEKA) and Origin 7.5 (OriginLab, Northampton, MA, USA). Single
cell current amplitudes were normalized for diﬀerences in cell size by
whole-cell membrane capacitance. All data are presented as
means ± standard error of the mean (S.E.M.). Diﬀerences between
means of two groups were tested by ANOVA using SPSS 13.0 (SPSS
Inc., Cary, NC, USA). Statistical signiﬁcance was taken at P < 0.05.3. Results
3.1. RT-PCR analysis
To assess gene expression of Kir2.1, Kir2.2 and Kir2.3 in the
control group and the Kir2.3 knock-down group, total RNA
was extracted from cultured cardiomyocytes at days 1–3 and
then subjected to semi-quantitative RT-PCR. As a result, the
mRNA levels of Kir2.1, Kir2.2 and Kir2.3 in the control group
were unchanged throughout the experiments (Fig. 1A). No dif-
ference was observed in Kir2.1 and Kir2.2 levels between the
control group and the Kir2.3 knock-down group. In contrast,
Kir2.3 mRNA almost disappeared in the Kir2.3 knock-down
group after 24 h of transfection (Fig. 1B).
3.2. Western blotting
Fig. 1C illustrates the representative gel for Kir2.1 and
Kir2.2, with bands detected at the expected molecular mass.
Quantitatively, the expression of Kir2.1 and Kir2.2 protein
Fig. 1. RNAi-induced Kir2.3 knock-down. (A) A RT-PCR product of Kir2.1–2.3 mRNA of control group and Kir2.3 knock-down group. (B)
Quantiﬁcation of Kir2.1–2.3 mRNA of control group and Kir2.3 knock-down group. *: P < 0.001, vs. Control. (C) Kir2.1–2.3 protein expression of
control group and Kir2.3 knock-down group. (D) Kir2.1–2.3 protein quantiﬁcation after RNA interference. *: P < 0.001, vs. Kir2.1 or Kir2.2. (E)
Immunoﬂuorescent staining of control group and Kir2.3 knock-down group (·560).
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knock-down group before and after Kir2.3 interference (Fig.
1D). In contrast, signal of Kir2.3 knock-down group, which
is displayed in Fig. 1C, demonstrated that Kir2.3 protein
was greatly down-regulated to 19.9 ± 3.2% of that in the con-
trol group at days 2–3 (Fig. 1D).3.3. Confocal microscopy
Kir2.1, Kir2.2 and Kir2.3 could be detected in the neonatal
cardiomyocytes of the control group from the 1st day to 3rd
day. Moreover, their ﬂuorescent density was invariable. Simi-
lar ﬂuorescent staining of Kir2.1 and Kir2.2 was also observed
in the Kir2.3 knock-down group before and after RNA inter-
ference (Fig. 1E). The ﬂuorescent density of Kir2.3, however,
was reduced dramatically in the Kir2.3 knock-down group as
compared with that of the control group within 2–3 days (con-trol vs. knock-down: 27.2 ± 6.0, n = 5 vs. 4.1 ± 1.0 n = 5,
P < 0.001). These phenomena were consistent with the above
Western blot data (Fig. 1D).3.4. Eﬀect of Kir2.3 knock-down on IK1 currents
To detect IK1 currents in control and Kir2.3 knock-down
NRCM, whole-cell voltage-clamp recordings were made on
dissociated neonatal ventricular myocytes. Block-iT labeled
NRCM was selected to record the IK1 currents. Representative
inward currents were recorded from individual ventricular
myocytes isolated from control and Kir2.3 knock-down
groups (Fig. 2A). Currents were evoked by voltage steps from
120 to 20 mV (in 20 mV increments) from a holding poten-
tial of 40 mV. Notably, IK1 currents of Kir2.3 knock-down
NRCM were less than that of the control. The steady state in-
ward currents at 120 mV (normalized to cellular capaci-
Y. He et al. / FEBS Letters 582 (2008) 2338–2342 2341tance) were as follows: control vs. knock-down: 5.0 ± 0.2 pA/
pF(n = 7) vs. 1.1 ± 0.2 pA/pF (n = 5), respectively. There was
a signiﬁcant diﬀerence (P < 0.001) (Fig. 2B).4. Discussion
A major ﬁnding of this study is that Kir2.3 channel subunit
is essential for normal native IK1 currents in the neonatal rat
cardiomyocytes.
Previous studies showed that the deletion of Kir2.1 subunit
almost eliminated the IK1 currents, and the deletion of Kir2.2
subunit reduced the IK1 currents by 50% [15]. Our data demon-
strated that IK1 current densities in the Kir2.3 knock-down
cardiomyocytes were decreased by about 80%. Therefore,
Kir2.3 subunit also plays an important role in IK1 currents.
Unlike the other subunit of Kir2.x channels, Kir2.3 is di-
rectly coupled to the G-protein, which contributes to cell–cell
communication [20]. It has been reported that Kir2.3 is inhib-
ited by protein kinase C in Xenopus oocytes, while the Kir2.1
is not aﬀected by protein kinase C [21]. Further evidence dem-
onstrated that Kir2.3 is most sensitive to internal pH
(pK = 6.9) and metabolic inhibitors produced by ischemia con-
dition, whereas Kir2.1 least sensitive (pK = 5.9) [22]. Addition-
ally, Kir2.3 subunit is modulated by polyamines, which
regulate the physiological function of inward rectiﬁcation
and hence cell excitability [23]. Thus, it is likely that various
physiological and pathophysiological conditions may aﬀect
IK1 currents by regulating Kir2.3 subunits.
Cohen et al. found that (1) Gbc co-expression with Kir2.1
yields no eﬀect on IK1-like currents produced by Kir2.1; (2)
Gbc co-expression with Kir2.3 abolishes IK1-like currents pro-
duced by Kir2.3; (3) when Kir2.1 and Kir2.3 are co-expressedB
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Fig. 2. Eﬀect of Kir2.3 knock-down on native IK1 current. (A) Representa
densities of control NRCM (n = 7) and knock-down NRCM (n = 5).with the Gbc, almost no current can be recorded [20]. Thus, we
speculate that Kir2.3 subunits may interact with Kir2.1 sub-
units. This speculation may be further conﬁrmed by the ﬁnding
that Kir2.1 and Kir2.3 channels can be co-immunoprecipitated
in membrane extracts from isolated guinea pig cardiomyocytes
[14]. Interestingly, the co-expression of a dominant-negative
Kir2.1 subunits with Kir2.2 subunits has no eﬀect on resulting
IK1 currents [13], suggesting that Kir2.1 and Kir2.2 subunit
may not co-assemble.
It is possible that Kir2.1 and/or Kir2.2 subunits expres-
sions are aﬀected by Kir2.3 knock-down in that Kir2.3 sub-
unit co-assembles with Kir2.1 and/or Kir2.2 to form the
heterogeneous IK1 current [24]. To exclude the possibility,
the mRNA and protein levels of Kir2.1, Kir2.2 and Kir2.3
were detected, respectively. Our results indicated that the
stealth RNAi targeted to Kir2.3 did not interrupt the mRNA
expression, the protein synthesis, or the traﬃcking of Kir2.1
and/or Kir2.2.5. Conclusion
Kir2.3 subunit is potentially important for IK1 currents gen-
eration in native cardiomyocytes.
Acknowledgements: Supported by the National Science Fund for
Distinguished Young Scholars (30425016), the National Science Fund
of China (30330290, 30528011 and 30470961), the ‘‘973’’
(2007CB512100) and ‘‘863’’ Programmes (2007AA02Z438) of China,
the Programme Fund for Outstanding Medical Academic Leader of
Shanghai, China, the Programme Fund for Shanghai Subject Chief
Scientist, China, the Yangze Scholars Programme Fund by the Minis-
try of Education, China, and the Programme Fund for Innovative Re-
search Team by the Ministry of Education, China (all of the grants
were to Yi-Han Chen.).0 -60 -40 -20
Voltage (mV)
tive IK1 currents from control and knock-down NRCM. (B) Current
2342 Y. He et al. / FEBS Letters 582 (2008) 2338–2342References
[1] Dhamoon, A.S., Pandit, S.V., Sarmast, F., Parisian, K.R., Guha,
P., Li, Y., Bagwe, S., Taﬀet, S.M. and Anumonwo, J.M. (2004)
Unique Kir2.x properties determine regional and species diﬀer-
ences in the cardiac inward rectiﬁer K+ current. Circ. Res. 94,
1332–1339.
[2] Plaster, N.M., Tawil, R., Tristani-Firouzi, M., Canu´n, S.,
Bendahhou, S., Tsunoda, A., Donaldson, M.R., Iannaccone,
S.T., Brunt, E., Barohn, R., Clark, J., Deymeer, F., George, A.L.,
Fish, F.A., Hahn, A., Nitu, A., Ozdemir, C., Serdaroglu, P.,
Subramony, S.H., Wolfe, G., Fu, Y.H. and Pta´cek, L.J. (2001)
Mutations in Kir2.1 cause the developmental and episodic
electrical phenotypes of Andersens syndrome. Cell 105, 511–519.
[3] Priori, S.G., Pandit, S.V., Rivolta, I., Berenfeld, O., Ronchetti, E.,
Dhamoon, A., Napolitano, C., Anumonwo, J., di Barletta, M.R.,
Gudapakkam, S., Bosi, G., Stramba-Badiale, M. and Jalife, J.
(2005) A novel form of short QT syndrome (SQT3) is caused by a
mutation in the KCNJ2 gene. Circ. Res. 96, 800–807.
[4] Samie, F.H., Berenfeld, O., Anumonwo, J., Mironov, S.F.,
Udassi, S., Beaumont, J., Taﬀet, S., Pertsov, A.M. and Jalife, J.
(2001) Rectiﬁcation of the background potassium current: a
determinant of rotor dynamics in ventricular ﬁbrillation. Circ.
Res. 89, 1216–1223.
[5] Warren, M., Guha, P.K., Berenfeld, O., Zaitsev, A., Anumonwo,
J.M., Dhamoon, A.S., Bagwe, S., Taﬀet, S.M. and Jalife, J. (2003)
Blockade of the inward rectifying potassium current terminates
ventricular ﬁbrillation in the guinea pig heart. J. Cardiovasc.
Electrophysiol. 14, 621–631.
[6] McLerie, M. and Lopatin, A.N. (2003) Dominant-negative
suppression of I (K1) in the mouse heart leads to altered cardiac
excitability. J. Mol. Cell Cardiol. 35, 367–378.
[7] Li, J., McLerie, M. and Lopatin, A.N. (2004) Transgenic
upregulation of IK1 in the mouse heart leads to multiple
abnormalities of cardiac excitability. Am. J. Physiol. Heart Circ.
Physiol. 287, H2790–H2802.
[8] Noujaim, S.F., Pandit, S.V., Berenfeld, O., Vikstrom, K.,
Cerrone, M., Mironov, S., Zugermayr, M., Lopatin, A.N. and
Jalife, J. (2007) Up-regulation of the inward rectiﬁer K+ current (I
K1) in the mouse heart accelerates and stabilizes rotors. J.
Physiol. 578 (Pt 1), 315–326.
[9] Liu, G.X., Derst, C., Schlichtho¨rl, G., Heinen, S., Seebohm, G.,
Bru¨ggemann, A., Kummer, W., Veh, R.W., Daut, J. and Preisig-
Mu¨ller, R. (2001) Comparison of cloned Kir2 channels with
native inward rectiﬁer K+ channels from guinea-pig cardiomyo-
cytes. J. Physiol. 532, 115–126.
[10] Wible, B.A., De Biasi, M., Majumder, K., Taglialatela, M. and
Brown, A.M. (1995) Cloning and functional expression of an
inwardly rectifying K+ channel from human atrium. Circ. Res. 76,
343–350.
[11] Nakamura, T.Y., Artman, M., Rudy, B. and Coetzee, W.A.
(1998) Inhibition of rat ventricular IK1 with antisense oligonu-cleotides targeted to Kir2.1 mRNA. Am. J. Physiol. 274, H892–
H900.
[12] Picones, A., Keung, E. and Timpe, L.C. (2001) Unitary conduc-
tance variation in Kir2.1 and in cardiac inward rectiﬁer potassium
channels. Biophys. J. 81, 2035–2049.
[13] Tinker, A., Jan, Y.N. and Jan, L.Y. (1996) Regions responsible
for the assembly of inwardly rectifying potassium channels. Cell
87, 857–868.
[14] Preisig-Mu¨ller, R., Schlichtho¨rl, G., Goerge, T., Heinen, S.,
Bru¨ggemann, A., Rajan, S., Derst, C., Veh, R.W. and Daut, J.
(2002) Heteromerization of Kir2.x potassium channels contrib-
utes to the phenotype of Andersens syndrome. Proc. Natl. Acad.
Sci. USA 99, 7774–7779.
[15] Zaritsky, J.J., Redell, J.B., Tempel, B.L. and Schwarz, T.L. (2001)
The consequences of disrupting cardiac inwardly rectifying K (+)
current (IK1) as revealed by the targeted deletion of the murine
Kir2.1 and Kir2.2 genes. J. Physiol. 533, 697–710.
[16] Fast, V.G. and Kle´ber, A.G. (1994) Anisotropic conduction in
monolayers of neonatal rat heart cells cultured on collagen
substrate. Circ. Res. 75, 591–595.
[17] Hough, S.R., Clements, I., Welch, P.J. and Wiederholt, K.A.
(2006) Diﬀerentiation of mouse embryonic stem cells after RNA
interference-mediated silencing of OCT4 and Nanog. Stem Cells
24, 1467–1475.
[18] Fuster, G., Vicente, R., Coma, M., Grande, M. and Felipe, A.
(2002) One-step reverse transcription polymerase chain reaction
for semiquantitative analysis of mRNA expression. Meth. Find.
Exp. Clin. Pharmacol. 24, 253–259.
[19] Lee, D.C., Stenland, C.J., Hartwell, R.C., Ford, E.K., Cai, K.,
Miller, J.L., Gilligan, K.J., Rubenstein, R., Fournel, M. and
Petteway Jr., S.R. (2000) Monitoring plasma processing steps
with a sensitive Western blot assay for the detection of the prion
protein. J. Virol. Meth. 84, 77–89.
[20] Cohen, N.A., Sha, Q., Makhina, E.N., Lopatin, A.N., Linder,
M.E., Snyder, S.H. and Nichols, C.G. (2003) Inhibition of an
inward rectiﬁer potassium channel (Kir2.3) by G-protein bet-
agamma subunits. J. Biol. Chem. 271, 32301–32305.
[21] Henry, P., Pearson, W.L. and Nichols, C.G. (1996) Protein kinase
C inhibition of cloned inward rectiﬁer (HRK1/KIR2.3) K+
channels expressed in Xenopus oocytes. J. Physiol. 495 (Pt 3),
681–688.
[22] Collins, A. and Larson, M. (2002) Diﬀerential sensitivity of
inward rectiﬁer K+ channels to metabolic inhibitors. J. Biol.
Chem. 277, 35815–35818.
[23] Shyng, S.L., Sha, Q., Ferrigni, T., Lopatin, A.N. and Nichols,
C.G. (1996) Depletion of intracellular polyamines relieves inward
rectiﬁcation of potassium channels. Proc. Natl. Acad. Sci. USA
93, 12014–12019.
[24] Schram, G., Pourrier, M., Wang, Z., White, M. and Nattel, S.
(2003) Barium block of Kir2 and human cardiac inward rectiﬁer
currents: evidence for subunit-heteromeric contribution to native
currents. Cardiovasc. Res. 59, 328–338.
